Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors

Pituitary

Volumn 9, Issue 2, 2006, Pages 137-143

  Lombardero, Matilde ^a,b   Vidal, Sergio ^a,b   Hurta, Robert ^a   Román, Alba ^b   Kovacs, Kalman ^a   Lloyd, Ricardo V ^c   Scheithauer, Bernd W ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c MAYO CLINIC   (United States)

Author keywords

FGF; EGF; Flk 1 receptor; GH3 cells; Pituitary adenoma; TGF ; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL STRAIN GH3; CONTROLLED STUDY; HORMONAL REGULATION; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; LASER SCANNING CYTOMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; RAT STRAIN; TUMOR GROWTH; UPREGULATION;

ANIMALS; CELL LINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; PITUITARY GLAND, ANTERIOR; RATS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33749055521     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-006-9989-2     Document Type: Article

References (43)

1. Ferrara N (2001) Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280:C1358-1366
2. Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 29:10-14
3. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795-803
4. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA (2002) Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 99:11946-11950
5. Ogunshola OO, Antic A, Donoghue MJ, Fan SY, Kim H, Stewart WB, Madri JA, Ment LR (2002) Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 277:11410-11415
6. Sondell M, Sundler F, Kanje M (2000) Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 12:4243-4254
7. Christofori G, Naik P, Hanahan D (1995) Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol 9:1760-1770
8. Michel O, Hess A, Bloch W, Schmidt A, Stennert E, Addicks K (2001) Immunohistochemical detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR/Flk-1 in the cochlea of guinea pigs. Hear Res 155:175-180
9. Oberg-Welsh C, Sandler S, Andersson A, Welsh M (1997) Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro. Mol Cell Endocrinol 126:125-132
10. Meister B, Grunebach F, Bautz F, Brugger W, Fink FM, Kanz L, Mohle R (1999) Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur J Cancer 35:445-449
11. von Marschall Z, Cramer T, Hocker M, Burde R, Plath T, Schirner M, Heidenreich R, Breier G, Riecken EO, Wiedenmann B, Rosewicz S (2000) De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop. Gastroenterology 119:1358-1372
12. Xie B, Tam NN, Tsao SW, Wong YC (1999) Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat. Br J Cancer 81:1335-1343
13. Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW (2002) Angiogenesis in patients with craniopharyngiomas: Correlation with treatment and outcome. Cancer 94:738-745
14. Itakura J, Ishiwata T, Shen B, Kornmann M, Korc M (2000) Concomitant overexpression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer 85:27-34
15. Vidal S, Lloyd RV, Moya L, Scheithauer BW, Kovacs K (2002) Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary. J Histochem Cytochem 50:533-540
16. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA, Gittoes NJ (2002) Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87:4238-4244
17. Vidal S, Scheithauer BW, Kovacs K (2000) Vascularity in Nontumorous human pituitaries and incidental microadenomas: A morphometric study. Endocr Pathol 11:215-227
18. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA (2000) Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85:1159-1162
19. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR (1997) Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 18:1155-1161
20. Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR (2000) Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 16:253-260
21. Renner U, Lohrer P, Schaaf L, Feirer M, Schmitt K, Onofri C, Arzt E, Stalla GK (2002) Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology 143:3759-3765
22. Ray D, Melmed S (1997) Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228
23. Vidal S, Oliveira MC, Kovacs K, Scheithauer BW, Lloyd R (2000) Immunolocalization of vascular endothelial growth factor in the GH3 cell line. Cell Tissue Res 300:83-88
24. Ferrara N (2000) Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15-35; discussion 35-16
25. Giatromanolaki A (2001) Prognostic role of angiogenesis in non-small cell lung cancer. Anticancer Res 21:4373-4382
26. Gasparini G (2000) Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 5(Suppl 1):37-44
27. Reinmuth N, Parikh AA, Ahmad SA, Liu W, Stoeltzing O, Fan F, Takeda A, Akagi M, Ellis LM (2003) Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech 60:199-207
28. Goth MI, Hubina E, Raptis S, Nagy GM, Toth BE (2003) Physiological and pathological angiogenesis in the endocrine system. Microsc Res Tech 60:98-106
29. Kanellis J, Fraser S, Katerelos M, Power DA (2000) Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 278:F905-915
30. Tsuchiya N, Sato K, Akao T, Kakinuma H, Sasaki R, Shimoda N, Satoh S, Habuchi T, Ogawa O, Kato T (2001) Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. Tohoku J Exp Med 195:101-113
31. Ochoa AL, Mitchner NA, Paynter CD, Morris RE, Ben-Jonathan N (2000) Vascular endothelial growth factor in the rat pituitary: Differential distribution and regulation by estrogen. J Endocrinol 165:483-492
32. Komorowski J, Jankewicz J, Stepien H (2000) Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (βFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours. Cytobios 101:151-159
33. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV (2001) Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438:595-602
34. Vidal S, Horvath E, Kovacs K, Kuroki T, Lloyd RV, Scheithauer BW (2003) Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours. Histol Histopathol 18:679-686
35. Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L (1999) Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10:229-235
36. Heaney AP, Fernando M, Melmed S (2002) Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 109:277-283
37. Banerjee S, Saxena N, Sengupta K, Banerjee SK (2003) 17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway. Biochem Biophys Res Commun 300:209-215
38. Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U, Stalla GK (1999) Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20:71-95
39. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U (2001) Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 74:95-105
40. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H (2002) Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology 35:834-842
41. Ishikawa H, Heaney AP, Yu R, Horwitz GA, Melmed S (2001) Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 86:867-874
42. Heaney AP, Melmed S (2000) New pituitary oncogenes. Endocr Relat Cancer 7:3-15
43. Ravindranath N, Wion D, Brachet P, Djakiew D (2001) Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate. J Androl 22:432-443